Literature DB >> 21343575

Withdrawing FDA approval of midodrine after marketing.

Neil A Holtzman, Barbara Starfield.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21343575     DOI： 10.1001/jama.2011.161

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  2 in total

1.  Midodrine efficacy in orthostatic hypotension.

Authors:  M Hassan Murad; Balwinder Singh; Ajay A Parsaik
Journal:  J Gen Intern Med       Date:  2014-11       Impact factor: 5.128

2.  Midodrine as adjunctive support for treatment of refractory hypotension in the intensive care unit: a multicenter, randomized, placebo controlled trial (the MIDAS trial).

Authors:  Matthew H Anstey; Bradley Wibrow; Tharusan Thevathasan; Brigit Roberts; Khushi Chhangani; Pauline Yeung Ng; Alexander Levine; Alan DiBiasio; Todd Sarge; Matthias Eikermann
Journal:  BMC Anesthesiol       Date:  2017-03-21       Impact factor: 2.217
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.